Francois Roubille: Can Low-Dose Colchicine Prevent Atrial Fibrillation After CABG?
Francois Roubille, Head of the Intensive Care Unit at University Hospital of Montpellier, shared a post on LinkedIn about a recent article he and his colleagues co-authored, published in Archives of Cardiovascular Diseases, adding:
“New publication in Archives of Cardiovascular Diseases
We are delighted to share our recent publication on the COLPOAF study: “Low-dose colchicine for prevention of post-operative atrial fibrillation after bypass surgery”.
Huge congratulations to Valentin Roger, cardiology resident.
Publishing his research at this level during residency is a great achievement.
Background
Post-operative atrial fibrillation (POAF) is common after cardiac surgery and linked to worse outcomes. Standard-dose colchicine may reduce it but is often poorly tolerated. Could low-dose colchicine (0.5 mg/day), already recommended in coronary artery disease, help after CABG?
The study
A single-center, observational “before-after” study at Montpellier University Hospital:
- 206 CABG patients treated with low-dose colchicine
- 244 historical controls without colchicine
Key messages
- No significant reduction in POAF with low-dose colchicine: 11.2% vs 11.9% (HR 0.92; 95% CI 0.53–1.59).
- Acceptable safety profile: more gastrointestinal side effects (7.8% vs 2.5%), but no serious adverse events.
- Significantly lower CRP levels: the anti-inflammatory effect is real.
- POAF is driven mainly by the atrial substrate and the surgery: age, left atrial volume, history of supraventricular tachycardia and cardiopulmonary bypass time.
These findings generate hypotheses and support future randomized trials.
They will help refine the dose, timing and target population.
Many thanks to the whole team, including our cardiac surgery colleagues and the clinical research unit at Montpellier University Hospital: David Martinez, Thomas Gandet, Roland Demaria, Philippe Rouvière, Sofiène Souidène, Alessandru Nigolean, Marie-Clothilde Brunet, Florence Leclercq and Lionel Moulis.”
Title: Low-dose colchicine for the prevention of post-operative atrial fibrillation after bypass surgery: Results from the COLPOAF study
Authors: Valentin Roger, David Martinez, Thomas Gandet, Roland Demaria, Philippe Rouviere, Sofiene Souidene, Alexandru Nigolean, Marie Clothilde Brunet, Florence Leclercq, Lionel Moulis, François Roubille
Stay updated with Hemostasis Today.
-
Nov 8, 2026, 19:31Anna Kajaste-Rudnitski: Presenting AAV-Induced p53 Signalling in Human CNS Cells at ESGCT 26
-
Nov 8, 2026, 19:29David McIntosh: Cybersecurity Matters, but Blood Availability Remains the Bigger Challenge
-
Nov 8, 2026, 19:26Wenxue Ma: An Integrative Framework for Macrophage-Mediated Therapeutic Resistance in Cancer
-
Nov 8, 2026, 19:25Yildiz Yigit: Presenting a Polycythemia Vera Case at the MPN Subcommittee Session
-
Nov 8, 2026, 18:56Denis Oduor: Strengthening the Regulation and Delivery of Blood Transfusion and Transplantation Services
-
Nov 8, 2026, 18:28Raghavendra Rao: A Narrative Review on Chronic Venous Disease during Pregnancy
-
Nov 8, 2026, 17:57Dhiren Patel: PLD1-Derived Phospholipids Regulate NAD Kinase and ROS Production in Neutrophils
-
Nov 8, 2026, 17:48Andra T.: What Causes Antiphospholipid Syndrome? – Four Steps, not One Cause
-
Nov 8, 2026, 17:38Nasrin Samadi: Can a Normal Clotting Test Be Misleading?